智通财经APP获悉，港股今日小幅高开后走弱，三大指数盘中集体翻绿。截止收盘，恒生指数跌0.11% 或27.63点，报25774.14点，全日成交额为1571.31亿港元；恒生国企指数跌0.29%，报8913.83点；恒生 科技指数跌0.69%，报5488.89点。 东吴证券认为，港股或有短期行情，但仍建议保持观察。从中长期配置来看，当前位置有吸引力。短期 美股有望有"圣诞行情"，美股科技股有反弹迹象，港股科技有可能与美股科技形成共振，但解禁仍会对 港股形成扰动。此外，港股配置仍然需要控制仓位。该行担心一月美股科技仍有回调风险。 蓝筹股表现 盘面上，大型科技股涨跌不一，阿里巴巴涨0.55%，腾讯跌2.03%。国际金价再创历史新高，黄金股盘 中冲高后有所回落，山东黄金收涨逾4%；锂电池股表现活跃，赣锋锂业涨超4%，中创新航涨超3%；电 力设备股、内银股飘红。另一边，港股年底迎解禁潮，多股今日遭遇重挫，越疆跌超8%，三花智控盈 喜后仍跌超6%；光通信、机器人概念、芯片股等普遍承压。 1. 黄金股冲高回落。截至收盘，山东黄金(01787)涨4.64%，报37.86港元；招金矿业(01818)涨2.79%，报 33.1 ...

Core Viewpoint - The digital health service provider, Easy Health (stock code: 02661.HK), made a strong debut on the Hong Kong Stock Exchange, opening at HKD 50, a significant increase of 120.46% from its issue price of HKD 22.68, reflecting high investor interest and demand [1][2]. Company Overview - Easy Health offers comprehensive digital health services and health insurance solutions in China, including disease screening promotion, health check consultation, medical appointment services, and health product sales, primarily reaching individual users through online platforms [3]. - According to a report by Sullivan, Easy Health ranks tenth in the Chinese digital comprehensive health services and health insurance market based on revenue for 2024, and seventh in the segmented digital health services market [3]. Financial Performance - The company's revenue has shown rapid growth, increasing from RMB 394 million in 2022 to RMB 945 million in 2024, representing a growth of over 140% within two years [3]. - Although the adjusted net profit fluctuated during this period, decreasing from RMB 149 million in 2022 to RMB 84 million in 2024, the financial data for the first half of 2025 indicates a recovery, with revenue reaching RMB 656 million and adjusted net profit at RMB 51 million [3].

Core Viewpoint - The article highlights the upcoming IPO of Easy Health Group, emphasizing its significant growth driven by AI technology and its position in the digital health and insurance market in China [3][4]. Group 1: Company Overview - Easy Health Group plans to list on the Hong Kong Stock Exchange under the stock code "2661" [3]. - Established in 2014, Easy Health Group operates as a one-stop digital health and insurance service platform, with two main business pillars: digital comprehensive health services and digital comprehensive insurance services [4]. - As of June 30, 2025, the platform has 168 million registered users and approximately 59.7 million followers across various social media channels [4]. Group 2: Market Position - According to a report by Sullivan, Easy Health Group ranks 10th in China's digital comprehensive health and insurance service market based on projected 2024 revenue, and 7th in the digital health service market [4]. Group 3: User Demographics - Approximately 60.4% of users are aged between 20 and 45 years, indicating a younger user base that is likely to increase spending on health solutions as they experience life events such as marriage and childbirth [5]. - The younger demographic also presents significant upselling and cross-selling opportunities for the company [5]. Group 4: AI Technology Integration - AI technology is a crucial growth engine for Easy Health Group, with the proprietary AI technology stack, AIcare, serving as the core support for the platform [5]. - As of the last practical date, about 43.3% of the company's employees are involved in IT research and development [5]. - The company has registered 58 invention patents and 39 software copyrights related to its technological capabilities [5]. Group 5: Operational Efficiency - Easy Health Group has significantly improved operational efficiency and reduced costs through various technologies, including the Galaxy AI marketing platform, which has generated nearly 12.9 million business leads [6]. - The company has also launched generative AI tools, enhancing medical professionals' diagnostic and treatment capabilities [6]. Group 6: Financial Performance - Revenue figures for Easy Health Group from 2022 to 2024 are projected at 394 million, 490 million, and 945 million yuan, respectively, with a compound annual growth rate of 54.9% [6]. - In the first half of this year, the company's revenue grew by 84.7% year-on-year to 656 million yuan, with an adjusted net profit of 51.18 million yuan, reflecting an 11.3% increase [6]. Group 7: IPO Fund Utilization - The net proceeds from the IPO will primarily be used to enhance brand awareness, increase user engagement, strengthen partnerships, invest in medical research, improve AI and big data capabilities, expand into new regions and overseas markets, and for general corporate purposes [7].

经济观察网 近日，上海合作组织国家多功能经贸平台（上合家园）卫生可持续发展工作委员会正式成立。国内AI医疗头部企业医渡科技（2158.HK）凭借其 在国际数字健康领域的成功实践与系统化建设能力入选组织成员单位，医渡科技联合创始人、CEO徐济铭当选为委员会第一届理事。此次"成员单位"与"首 届理事"的双重身份认可，是对医渡科技技术实力、行业贡献及管理层专业能力的肯定，也标志着该公司在参与国际多边卫生合作、推动全球健康可持续发 展方面迈出关键一步。 上海合作组织国家多功能经贸平台是在上海合作组织秘书处和重庆市委市政府支持下，由上海合作组织实业家委员会、重庆两江新区管委会等共同搭建的以 经济作为核心的多领域、多功能、非营利性国际合作交流平台。 会上，上海合作组织国家多功能经贸平台总干事、重庆市政协港澳台侨和外事委员会副主任胡开强为委员会授牌，他在发言中指出，加强卫生健康领域合 作，促进卫生健康可持续发展，已成为历届上合组织各成员国元首重要共识。 商务部研究院国际发展合作研究所所长王泺作主题发言。她从政策研究与国际合作的高度，系统阐述了医药产业南向出海的战略意义与现实路径，特别提出 从"单点输血"到"体系赋能"的援外 ...

同时值得关注的是，医渡科技在国际多边合作舞台实现重要突破：上海合作组织国家多功能经贸平台 (上合家园)卫生可持续发展工作委员会近期正式成立，医渡科技成功入选组织成员单位;公司联合创始 人、CEO 徐济铭当选委员会第一届理事，双重认可标志着公司在国际数字健康合作领域的专业能力与 行业地位获得权威背书。 近年来，医渡科技的国际化战略布局稳步推进，业务和客户网络已拓展至全球六个地区。通过与当地政 府部门、医疗机构及科研院所深度协同，构建起了成熟的本土化合作生态，研发的智能化解决方案已广 泛落地于传染病监测预警、全民人口健康管理、AI 辅助诊疗、个性化健康管理等关键领域，持续以科 技力量赋能全球健康事业发展。 智通财经APP获悉，12月19日，医渡科技(02158)公告显示，当日以每股5.23港元的价格回购9.35万股， 回购金额约49万港元。12月以来，公司已回购11次，累计回购约344万股，总金额超1740万港元。以真 金白银持续夯实市场信心，彰显医渡科技对自身发展前景的坚定看好。 消息面上，医渡科技近期在行业认可与国际合作领域捷报频传。在香港城市大学数码医学研究院周年大 会上，公司创始人、董事长宫如璟女士获聘为 ...

Core Insights - Ant Group has officially upgraded its AI health application AQ to "Ant Aifu," marking a strategic shift from "medical AI tools" to "AI health companions" in the digital health sector [1][3] - The new "Aifu" app focuses on a "health+" strategy, boasting over 15 million monthly active users, making it one of the top five AI applications in China and the largest health management AI app [1][5] Strategic Shift - The upgrade signifies a transition from a functional tool to a companion, aiming to meet the unaddressed market demand for health promotion, disease prevention, and out-of-hospital management [1][3] - The product positioning reflects a market logic where AI is not just a cold tool but a trusted companion, enhancing user engagement and long-term value [3][4] Functional Enhancements - Aifu has undergone a systematic restructuring of its features, including a health companionship system that integrates data from various smart devices and allows for personalized health management [4][5] - The health Q&A capability has been upgraded to provide tailored responses based on continuous learning from user data, including a unique "AI clinic" mode for better symptom description [4][5] Platform Connectivity - Aifu emphasizes its role in connecting users with healthcare services rather than replacing doctors, linking to 300,000 real doctors for online consultations and integrating practical features like appointment scheduling and medication purchases [4][5] - The platform has already facilitated over 27 million consultations, showcasing its potential to alleviate pressure on public health systems by providing accessible health education and initial consultations [5][6] Market Positioning - With 55% of its users from third-tier cities, Aifu demonstrates strong penetration in grassroots markets, aligning with China's "Healthy China" strategy to enhance basic health services [5] - The app's daily interaction volume of over 5 million health inquiries indicates a robust demand for professional and convenient AI health services [5][6] Evolution Path - Ant Group's journey from "Anzhener" to "AQ" and now to "Aifu" illustrates a clear evolution in the digital health space, transitioning from regional pilots to nationwide promotion and from single-function tools to integrated ecosystems [5][6]

Group 1 - The company, Easy Health (02661), plans to conduct a global offering of 26.54 million shares from December 15 to December 18, 2025, with a share price of HKD 22.68, and expects trading to commence on December 23, 2025 [1] - Easy Health ranks 10th in China's digital integrated health services and health insurance market based on 2024 revenue, according to a report by Sullivan [1] - The company provides a comprehensive range of health-related services, including early disease screening, health check-ups, medical appointment services, and the sale of health products [1] Group 2 - The company has entered into a cornerstone investment agreement with 澳琴合鸣, which will subscribe for approximately 4.8018 million shares at the offering price, totaling around RMB 100 million [2] - The net proceeds from the global offering are estimated to be approximately HKD 513.4 million, with 40% allocated to enhancing brand awareness and user engagement, 20% for medical and real-world research, 20% for improving AI and big data capabilities, 10% for expanding into more regions and overseas markets, and 10% for working capital and other general corporate purposes [2]

Group 1 - Guangzhou Digital Technology Group held an investor conference on December 3, 2023, focusing on becoming a leading enterprise in digital technology through ecological integration [1] - The conference featured over 150,000 online viewers and included participation from five listed companies under the group [1] - The Vice Director of the State-owned Assets Supervision and Administration Commission of Guangzhou praised the group's contributions to the city's digital economy and innovation [1] Group 2 - The Chairman of Guangzhou Digital Technology Group emphasized a dual-driven strategy of "real economy + capital," focusing on technological innovation and capital operation [1] - The group aims to accelerate its layout in artificial intelligence, data elements, digital security, digital health, digital transportation, and digital finance [1] - The group is committed to being a responsible shareholder and promoting the collaborative development of its five listed companies [1] Group 3 - During the roadshow, various companies shared their business focuses and strategic layouts, including AI applications in finance and smart city solutions [2] - Guangzhou Yuntong Group is pursuing breakthroughs in AI, focusing on AI + financial technology, smart transportation, and other sectors [2] - Beijing Zhongke Jiangnan is enhancing fiscal management through AI and expanding its services in government fund management [2] Group 4 - Guangzhou Haige Communication aims to enhance high-end manufacturing and modern services by focusing on new production capabilities and combat capabilities [2] - Guangzhou Jiliang Testing Group is targeting emerging industries like aerospace and satellite internet, providing comprehensive quality assurance services [2] - Guangzhou Guangha Communication is consolidating its advantages in intelligent command and dispatch systems [3] Group 5 - The interactive session allowed investors to discuss topics such as technology research and development, market expansion, and performance growth with company management [3] - The atmosphere during the Q&A session was lively, indicating strong investor interest and engagement [3]

Core Viewpoint - QingSong Health Corporation has passed the listing hearing on the Hong Kong Stock Exchange, marking its official entry into the capital market as a leading health technology platform in China [2] Group 1: Business Overview - Since its establishment in 2014, QingSong Health Corporation has focused on innovation in digital health and smart insurance, supported by significant investments from top-tier institutions like IDG Capital and Tencent [3] - The company operates a dual-driven model with "digital comprehensive health" and "digital comprehensive insurance," creating significant synergies between the two business segments [3] Group 2: Digital Health Business Growth - The digital health segment is experiencing rapid expansion, with a focus on customized digital marketing solutions for pharmaceutical companies and charities, resulting in a substantial increase in health-related content production [4] - The company has organized over 1,000, 1,500, and 4,800 screening events from 2022 to 2025, significantly increasing user engagement and brand recognition [5] Group 3: Digital Insurance Business - The digital insurance segment has become a profit pillar, with a strong cash flow generation model based on fixed fees from service usage, enhancing financial resilience [6] - Insurance brokerage revenue reached 50.7 million yuan in the first half of 2025, with a growing number of policyholders and policies issued over the years [6] Group 4: User Base and Competitive Advantage - As of June 30, 2025, the company has nearly 170 million registered users, with a significant portion being young adults, providing opportunities for cross-selling and long-term value extraction [7] - The company has established a robust ecosystem that enhances brand influence and facilitates user acquisition through data-driven strategies [7][10] Group 5: Financial Performance - The company reported a revenue of 656.1 million yuan in the first half of 2025, an increase of 84.8% year-on-year, indicating successful strategic transformation towards technology and digital marketing [12] - Adjusted net profit for the first half of 2025 was 51.2 million yuan, reflecting a growth of 11.4% compared to the previous year [12] Group 6: Market Potential - The Chinese health service market is projected to grow from 622.61 billion yuan in 2020 to 814.94 billion yuan in 2024, with a compound annual growth rate of 7.0%, indicating significant expansion opportunities for the company [13]

Group 1 - The 2025 Data Element Development Conference was held in Hangzhou High-tech Zone, focusing on the theme "Data Empowerment, Intelligent Creation of the Future" [1] - The conference gathered numerous industry experts to discuss the latest developments and future trends in the data element industry, releasing multiple research findings to support industry growth [1] - A keynote speech by John Buck Award winner Yu Changbin highlighted the integration of AI and biological big data in digital health, showcasing technological breakthroughs and practical applications [1] Group 2 - Yan Shu, Deputy Chief Engineer of the Cloud Computing and Big Data Research Institute of China Academy of Information and Communications Technology, presented and interpreted the "Data Element Development Report (2025)", discussing the reconstruction of data element value in the intelligent era [2] - The report summarized the latest developments in supply, circulation, application, and security of data elements in China over the past year, identifying key challenges and future trends [2] - Jiang Chunyu, Director of the Cloud Computing and Big Data Research Institute, shared insights on the construction of high-quality data sets across ten key industries, addressing challenges and proposing recommendations for institutional building and technical development [2][3]